Skip to main content
Premium Trial:

Request an Annual Quote

Affy Officials: ParAllele Acquisition Closed Friday

NEW YORK, Oct. 24 (GenomeWeb News) - Affymetrix was scheduled to close its acquisition of ParAllele by the end of the day on Friday, according to company officials who spoke during a conference call to discuss the company's third-quarter earnings after market close on Thursday.


On Friday, an Affymetrix spokesman confirmed the company's plan to wrap up the acquisition by the end of the day, telling GenomeWeb News that Affymetrix expected to formally announce it today.   


Affymetrix announced its plans to purchase ParAllele for $120 million in stock in June. The acquisition was originally scheduled to close by Sept. 30.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.